Cel AI PLC is a company that has established itself in the biosynthetic CBD and CBG retail business. The company was admitted to the Official List by way of a Standard Listing under Chapter 14 of the Listing Rules and began trading on the London Stock Exchange on 26 February 2021. The company is incorporated in England and Wales and has undergone significant strategic changes in its operations.
As of the year-end, the company has one subsidiary, King Tide Carbon Pte. Ltd., which was incorporat...
Cel AI PLC is a company that has established itself in the biosynthetic CBD and CBG retail business. The company was admitted to the Official List by way of a Standard Listing under Chapter 14 of the Listing Rules and began trading on the London Stock Exchange on 26 February 2021. The company is incorporated in England and Wales and has undergone significant strategic changes in its operations.
As of the year-end, the company has one subsidiary, King Tide Carbon Pte. Ltd., which was incorporated in Singapore as part of the company’s acquisition on May 9, 2023. The company has made a strategic decision to exit the skincare business and cease the active management of subsidiaries, including King Tide Carbon Singapore. This decision reflects the company’s focus on its core business areas and the desire to streamline operations for better efficiency and effectiveness.
Business Segments
The company operates primarily in the biosynthetic CBD and CBG retail sector. The company’s strategic focus has shifted towards artificial intelligence and AI agent sectors, reflecting its commitment to innovation and adaptation in a rapidly changing market. The company has made significant investments in exploring and developing businesses within these sectors, which are expected to drive future growth and expansion.
The company’s decision to exit the skincare business and cease the management of subsidiaries, including King Tide Carbon, indicates a strategic pivot towards more promising and aligned business segments. This realignment allows the company to concentrate its resources and efforts on areas with higher potential for profitability and market relevance.
Business Strategy
The company’s business strategy is centered around innovation, sustainability, and ethical practices. The company aims to leverage its expertise in biosynthetic CBD and CBG products while exploring new opportunities in the artificial intelligence sector. This dual focus allows the company to diversify its offerings and reduce reliance on any single market segment.
The company’s strategic decisions are guided by a commitment to ethical values and behaviors, which are integral to its corporate culture. The company actively seeks to minimize its environmental impact through various initiatives, including promoting remote work and utilizing digital communication tools to reduce travel. This approach not only aligns with the company’s values but also enhances operational efficiency.
The company’s governance framework supports its strategic objectives, with a Board that regularly reviews its structure, composition, and performance. This ongoing evaluation ensures that the company remains agile and capable of adapting to changing market conditions. The company’s focus on risk management is also a critical component of its strategy, as it seeks to identify and mitigate potential threats while capitalizing on emerging opportunities.
Products and Services
The company offers a range of products and services primarily focused on biosynthetic CBD and CBG. The company has established itself in the retail market for these products, which are derived from natural sources and are designed to meet the growing consumer demand for alternative wellness solutions.
In addition to its core product offerings, the company is actively exploring opportunities in the artificial intelligence sector. This includes the development of AI agents and related technologies that are expected to enhance the company’s product portfolio and provide additional value to customers.
Geographical Markets Served
The company primarily serves the UK market. The company’s recent acquisition of King Tide Carbon Pte. Ltd. in Singapore reflects its intent to expand its operational footprint and explore new market opportunities.
Customers
The company serves a diverse range of customers within the wellness market, particularly those seeking natural alternatives through its biosynthetic CBD and CBG products.
Sales and Marketing
The company employs various modes of sales and marketing to promote its products and services. The company utilizes digital marketing channels to reach its target audience effectively, leveraging online platforms to engage with consumers and promote its offerings.
The company’s distribution channels are designed to ensure that its products are accessible to a wide range of customers, particularly those seeking natural wellness solutions. By focusing on innovative marketing strategies and ethical practices, the company aims to build a strong brand presence in the biosynthetic CBD and CBG markets.
History
The company was incorporated in 2018. It was formerly known as Cellular Goods PLC and changed its name to Cel AI PLC in 2024.
Das Analystenkursziel zeigt auf einen Blick die Mindest-, Höchst- und Durchschnittserwartung der Analysten.
